[Effect of microRNA-133b on Myocardial Fibrosis]

Song Lin Zhang1, Fen Ling Fan1, Feng Wei1

  • 1Department of Structural Heart Disease,the First Affiliated Hospital of Xiߣan Jiaotong University,Xiߣan 710061,China.

Insights

MicroRNA-133b (miR-133b) inhibits cardiac fibroblast proliferation and reduces fibrosis markers by targeting connective tissue growth factor (CTGF). This suggests miR-133b has therapeutic potential for cardiac fibrosis.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • MicroRNA Research

Background:

  • Cardiac fibrosis is a significant contributor to heart failure.
  • MicroRNAs play crucial roles in regulating cardiac structure and function.
  • The specific role of microRNA-133b (miR-133b) in cardiac fibrosis remains to be fully elucidated.

Purpose of the Study:

  • To investigate the effect of miR-133b on cardiac fibroblast (CF) proliferation and activation.
  • To explore the underlying mechanism by which miR-133b influences cardiac fibrosis.
  • To identify potential therapeutic targets for mitigating cardiac fibrosis.

Main Methods:

  • Human cardiac fibroblasts (CFs) were cultured and transfected with miR-133b mimics or inhibitors.
  • Cell proliferation was assessed using CCK8 assays.
  • Gene and protein expression of fibrosis markers (CTGF, α-SMA, collagen I, collagen III) were quantified via qRT-PCR and Western blot.
  • Bioinformatics and dual-luciferase reporter assays were employed to validate miR-133b targets.

Main Results:

  • Overexpression of miR-133b significantly decreased CF proliferation and downregulated CTGF, α-SMA, collagen I, and collagen III expression.
  • Knockdown of miR-133b significantly increased CF proliferation and upregulated these fibrosis markers.
  • Dual-luciferase assays confirmed that miR-133b directly targets CTGF.

Conclusions:

  • miR-133b plays a protective role against cardiac fibrosis by inhibiting CF activation and proliferation.
  • Targeting CTGF is a key mechanism through which miR-133b exerts its antifibrotic effects.
  • miR-133b holds promise as a therapeutic agent for treating cardiac fibrosis.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
316
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K